21-Hydroxylase Deficiency Detected in Neonatal Screening: High Probability of False Negativity in Late Onset Form
Experimental and Clinical Endocrinology & Diabetes · 01.01.2025 · 133 (01) · 20-24
DOI: 10.1055/a-2433-0891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.01.2025. Verfasst von Jan David und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Children and Adolescents, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Repu…. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Neonatal Screening, 17-alpha-Hydroxyprogesterone, Steroid 21-Hydroxylase. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Aim
Despite the high sensitivity of neonatal screening in detecting the classical form of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, one of the unclear issues is identifying asymptomatic children with late onset forms. The aim of this nationwide study was to analyse the association between genotype and screened level of 17-hydroxyprogesterone in patients with the late onset form of 21-hydroxylase deficiency and to quantify false negativity.
Methods
In the Czech Republic, 1,866,129 neonates were screened (2006–2022). Among this cohort, 159 patients were confirmed to suffer from 21-hydroxylase deficiency, employing the 17-hydroxyprogesterone birthweight/gestational age-adjusted cut-off limits, and followed by the genetic confirmation. The screening prevalence was 1:11,737. Another 57 patients who were false negative in neonatal screening were added to this cohort based on later diagnosis by clinical suspicion. To our knowledge, such a huge nationwide cohort of false negative patients has not been documented before.
Results
Overall, 57 patients escaped from neonatal screening in the monitored period. All false negative patients had milder forms. Only one patient had simple virilising form and 56 patients had the late onset form. The probability of false negativity in the late onset form was 76.7%. The difference in 17-hydroxyprogesterone screening values was statistically significant (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Children and Adolescents, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
- Department of Internal Hematology and Oncology, Centre of Molecular Biology and Genetics, Masaryk University and University Hospital Brno, Brno, Czech Republic.
- Department of Clinical Biochemistry, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.
- Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- Department of Biostatistics, National Institute of Public Health, Prague, Czech Republic.
Zitieren
APA
David, J., Hrubá, Z., Vinohradská, H., Hedelová, M., Fialová, A., & Votava, F. (2025). 21-Hydroxylase Deficiency Detected in Neonatal Screening: High Probability of False Negativity in Late Onset Form. Experimental and Clinical Endocrinology & Diabetes, 133(01), 20-24. https://doi.org/10.1055/a-2433-0891
Vancouver
David J, Hrubá Z, Vinohradská H, Hedelová M, Fialová A, Votava F. 21-Hydroxylase Deficiency Detected in Neonatal Screening: High Probability of False Negativity in Late Onset Form. Experimental and Clinical Endocrinology & Diabetes. 2025;133(01):20-24. doi:10.1055/a-2433-0891
BibTeX
@article{David2025,
author = {David, Jan and Hrubá, Zuzana and Vinohradská, Hana and Hedelová, Monika and Fialová, Alena and Votava, Felix},
title = {21-Hydroxylase Deficiency Detected in Neonatal Screening: High Probability of False Negativity in Late Onset Form},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2025},
volume = {133},
number = {01},
pages = {20--24},
doi = {10.1055/a-2433-0891}
}
EUVIMED